The novel latex agglutination turbidimetric immunoassay system for simultaneous measurements of calprotectin and hemoglobin in feces
- Author:
Sakiko HIRAOKA
1
;
Shiho TAKASHIMA
;
Toshihiro INOKUCHI
;
Asuka NAKARAI
;
Masahiro TAKAHARA
;
Keita HARADA
;
Yasuhiro SEKI
;
Katsunori WATANABE
;
Jun KATO
;
Hiroyuki OKADA
Author Information
- Publication Type:Original Article
- Keywords: Colitis, ulcerative; Fecal calprotectin; Quantitative fecal immunochemical test; Latex agglutination turbidimetric immunoassay; Mucosal healing
- MeSH: Agglutination; Biomarkers; Classification; Colitis, Ulcerative; Colonoscopy; Enzyme-Linked Immunosorbent Assay; Feces; Humans; Immunoassay; Inflammatory Bowel Diseases; Latex; Leukocyte L1 Antigen Complex; ROC Curve; Sensitivity and Specificity
- From:Intestinal Research 2019;17(2):202-209
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND/AIMS: Fecal calprotectin (Fcal) as well as the fecal immunochemical test (FIT) are useful biomarkers for detecting activity and mucosal healing in inflammatory bowel diseases. Here, we report the performance of simultaneous measurements of Fcal and FIT for ulcerative colitis (UC) patients using the newly-developed latex agglutination turbidimetric immunoassay (LATIA) system. METHODS: Fcal and hemoglobin were measured by the LATIA system in 152 UC patients who underwent colonoscopy. Fcal was also quantified with a conventional enzyme-linked immunosorbent assay (ELISA). Fecal markers were evaluated in conjunction with the mucosal status of UC, which was assessed via the Mayo endoscopic subscore (MES) classification. RESULTS: The LATIA system could quantify calprotectin and hemoglobin simultaneously with the same fecal samples within 10 minutes. The values of the Fcal-LATIA closely correlated with those of the Fcal-ELISA (Spearman rank correlation coefficient, r=0.84; P<0.0001). The values of Fcal for each assay and the FIT all significantly correlated with the MESs (Spearman rank correlation coefficient, Fcal-LATIA: r=0.58, Fcal-ELISA: r=0.55, and FIT: r=0.72). The mucosal healing predictability (determined by an MES of 0 alone) of the Fcal-LATIA, Fcal-ELISA, and FIT-LATIA with the cutoffs determined by receiver operating characteristic curve analysis was 0.79, 0.78, and 0.92 for sensitivity, respectively, and 0.78, 0.69, and 0.73 for specificity, respectively. CONCLUSIONS: The performance of the novel Fcal-LATIA was equivalent to that of the conventional Fcal assay. Simultaneous measurements with FITs would promote the clinical relevance of fecal biomarkers in UC.
